Citizens JMP lowered the firm’s price target on Alkami (ALKT) to $40 from $46 and keeps an Outperform rating on the shares. Alkami reported “mixed” Q3 results and lowered its revenue guidance for the year, in part, due to some new client implementations shifting out to Q4, but increased its profitability outlook, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKT: